Palisade Retained Earnings vs Long Term Debt Analysis
PALI Stock | USD 7.29 0.21 2.97% |
Palisade Bio financial indicator trend analysis is much more than just breaking down Palisade Bio prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Palisade Bio is a good investment. Please check the relationship between Palisade Bio Retained Earnings and its Long Term Debt accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.
Retained Earnings vs Long Term Debt
Retained Earnings vs Long Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Palisade Bio Retained Earnings account and Long Term Debt. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Palisade Bio's Retained Earnings and Long Term Debt is -0.08. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Palisade Bio, assuming nothing else is changed. The correlation between historical values of Palisade Bio's Retained Earnings and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Palisade Bio are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Retained Earnings i.e., Palisade Bio's Retained Earnings and Long Term Debt go up and down completely randomly.
Correlation Coefficient | -0.08 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Long Term Debt
Long-term debt is a debt that Palisade Bio has held for over one year. Long-term debt appears on Palisade Bio balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Palisade Bio balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.Most indicators from Palisade Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Palisade Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.As of now, Palisade Bio's Enterprise Value Over EBITDA is increasing as compared to previous years. The Palisade Bio's current Enterprise Value Multiple is estimated to increase to 0.46, while Enterprise Value is projected to decrease to (8.9 M).
2021 | 2023 | 2024 (projected) | Reconciled Depreciation | 2K | 4K | 3.3K | Cost Of Revenue | 168K | 192.1K | 176.4K |
Palisade Bio fundamental ratios Correlations
Click cells to compare fundamentals
Palisade Bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Palisade Bio fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.6M | 3.0M | 12.5M | 15.8M | 14.1M | 12.3M | |
Other Current Liab | 368.0K | 3.3M | 779K | 991K | 891.9K | 983.6K | |
Total Current Liabilities | 1.2M | 8.1M | 2.5M | 3.0M | 2.6M | 3.4M | |
Total Stockholder Equity | 5.1M | (16.6M) | 7.4M | 12.5M | 11.3M | 6.2M | |
Property Plant And Equipment Net | 242.7K | 280K | 112K | 310K | 208K | 233.1K | |
Net Debt | (4.9M) | 708K | (10.3M) | (12.0M) | (10.8M) | (10.2M) | |
Retained Earnings | (222.0M) | (68.0M) | (94.6M) | (109.2M) | (121.5M) | (127.6M) | |
Accounts Payable | 824.4K | 3.6M | 1.5M | 1.8M | 864K | 1.6M | |
Cash | 5.1M | 713K | 10.5M | 12.4M | 12.4M | 8.5M | |
Non Current Assets Total | 937.0K | 2.1M | 138K | 1.0M | 724K | 1.1M | |
Non Currrent Assets Other | 25.3K | 1.8M | 26K | 694K | 38K | 36.1K | |
Cash And Short Term Investments | 5.1M | 713K | 10.5M | 12.4M | 14.2M | 10.3M | |
Common Stock Total Equity | 151.6K | 182.1K | 38.7K | 173.0K | 155.7K | 147.9K | |
Common Stock Shares Outstanding | 7.3K | 55.5K | 187.0K | 880.3K | 9.3M | 9.7M | |
Liabilities And Stockholders Equity | 6.6M | 3.0M | 12.5M | 15.8M | 18.1M | 12.2M | |
Non Current Liabilities Total | 233.1K | 11.5M | 2.7M | 272K | 153K | 145.4K | |
Other Current Assets | 510.9K | 2.4M | 1.9M | 2.4M | 2.7M | 2.8M | |
Other Stockholder Equity | 227.1M | 51.4M | 101.9M | 121.6M | 139.9M | 139.3M | |
Total Liab | 1.5M | 19.6M | 5.1M | 3.3M | 2.7M | 2.6M | |
Property Plant And Equipment Gross | 268.1K | 10.8K | 112K | 310K | 208K | 218.2K | |
Total Current Assets | 5.6M | 896K | 12.4M | 14.7M | 13.3M | 11.2M | |
Accumulated Other Comprehensive Income | (821.9K) | (902.3K) | (6.2K) | (734.0) | (660.6) | (693.63) | |
Intangible Assets | 883.5K | 763.5K | 668.9K | 147.1K | 169.2K | 160.7K | |
Common Stock | 38.7K | 28K | 143K | 30K | 27K | 25.7K | |
Net Receivables | 21.1K | 59K | 150K | 1.4M | 1.7M | 1.7M | |
Other Assets | 13.9K | 24.0K | 26K | 157.6K | 29.9K | 48.2K | |
Capital Surpluse | 217.1M | 219.5M | 227.1M | 247.8M | 285.0M | 245.4M | |
Property Plant Equipment | 5K | 420K | 280K | 112K | 100.8K | 167.9K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Palisade Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Palisade Bio's short interest history, or implied volatility extrapolated from Palisade Bio options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Palisade Bio using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Palisade Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |
Is Palisade Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.00) | Revenue Per Share 0.548 | Return On Assets (0.54) | Return On Equity (1.03) |
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.